Company / SG&A per Share
Neogen SG&A per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.01
FY2024
5-year range
$0.78 / $1.87
FY2020-FY2024
Trend
-45.6%
vs FY2023
Sector context
#132 of 150
Health Care
What the data says
Neogen's sg&a per share of $1.01 is lower than 88% of companies in the Health Care sector (FY2024). SG&A per Share has fluctuated over the past 9 years, ranging from $0.78 in FY2021 to $1.87 in FY2022.
Based on SEC 10-K filings.
1.01 in FY2024 with a 5-year CAGR of +3.3%.
Improved from $1.87 to $1.01 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +8.9%
- 5-Year CAGR
- +3.3%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 150This company $1.01 Sector average $11878.17
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2024, sg&a per share decreased 45.6% year-over-year.
- Ranks #132 out of 150 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2022.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $1.01 | -45.6% |
| FY2023 | $1.85 | -0.9% |
| FY2022 | $1.87 | +139.6% |
| FY2021 | $0.78 | -20.3% |
| FY2020 | $0.98 | +14.4% |
| FY2019 | $0.86 | +7.0% |
| FY2018 | $0.80 | -21.4% |
| FY2017 | $1.02 | +10.6% |
| FY2016 | $0.92 | +16.0% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026